Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626284 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of NRP for DCD Heart Transplantation
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04626284 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 10 participants.
The verdict
NCT04626284, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a prospective, observational, pilot trial to evaluate the feasibility of heart transplantation using normothermic regional perfusion (NRP) donation after donor circulatory death (DCD). Normothermic regional perfusion utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart prior to final acceptance for transplantation without the imminent danger of ongoing warm ischemia.
Interventions
- PROCEDURE Heart Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-01-03 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04626284
The ClinicalTrials.gov registry entry for NCT04626284 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heart Transplantation is the first listed.
NCT04626284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04626284 about?
NCT04626284 is a clinical study titled "Safety and Effectiveness of NRP for DCD Heart Transplantation". This is a prospective, observational, pilot trial to evaluate the feasibility of heart transplantation using normothermic regional perfusion (NRP) donation after donor circulatory death (DCD). Normothermic regional perfusion utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypa...
What is the current status of trial NCT04626284?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-01-03. Estimated completion is 2022-04-08.
What interventions are being tested in trial NCT04626284?
The interventions under investigation include: Heart Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04626284?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.